Emerging Infectious Diseases ( IF 7.2 ) Pub Date : 2024-11-15 , DOI: 10.3201/eid3012.240467 Pattriya Jirawattanadon, Sumanas Bunyaratavej, Charussri Leeyaphan, Piriyaporn Chongtrakool, Panitta Sitthinamsuwan, Waratchaya Panjapakkul, Suthasanee Prasertsook, Phuwakorn Saengthong-aram, Nicha Wareesawetsuwan, Julaluck Posri, Penvadee Pattanaprichakul
We analyzed clinical manifestations, antifungal susceptibility, and treatment outcomes of cutaneous sporotrichosis in Thailand during 2018–2022. The study included 49 patients whose mean age was 58.7 (SD 16.9) years; 65.3% were female and 34.7% male. A history of cat exposure was reported in 32 (65.3%) patients who had a significantly higher prevalence of upper extremity lesions than did those without cat contact (90.6% vs. 41.7%; adjusted odds ratio 18.9 [95% CI 3.2–92.9]). Among patients >60 years of age, lesions were more likely to be nonpustular than for patients <60 years of age (82.1% vs. 52.4%; p = 0.033). All 9 isolates tested for antifungal drug susceptibility exhibited an itraconazole MIC of <1 μg/mL. Oral itraconazole monotherapy was effective; the median time-to-cure was 180 days (interquartile range 141–240 days). Physicians should heighten their awareness of potential sporotrichosis causes, particularly when a history of animal contact exists.
中文翻译:
泰国新发人畜共患皮肤孢子丝菌病的临床表现、抗真菌药物敏感性和治疗结局
我们分析了 2018-2022 年泰国皮肤孢子丝菌病的临床表现、抗真菌药敏试验和治疗结果。该研究包括 49 名患者,平均年龄为 58.7 (SD 16.9) 岁;65.3% 为女性,34.7% 为男性。据报道,32 例 (65.3%) 患者有猫暴露史,这些患者的上肢病变患病率显著高于没有猫接触的患者 (90.6% vs. 41.7%;校正比值比 18.9 [95% CI 3.2-92.9])。在 >60 岁患者中,病变比 <60 岁患者更可能是非脓疱性的 (82.1% vs. 52.4%;p = 0.033)。所有 9 株抗真菌药物敏感性检测的分离株均显示伊曲康唑 MIC 为 <1 μg/mL。口服伊曲康唑单药治疗有效;中位治愈时间为 180 天 (四分位距 141-240 天)。医生应提高对潜在孢子丝菌病病因的认识,尤其是当存在动物接触史时。